Find Federal Grants
Maternal Health Research Collaborative for Minority-Serving Institutions (MH-RC-MSI) Research Centers (RCs)
Health Resources and Services Administration · HRSA-23-112
Health Resources and Services Administration · HRSA-23-108
A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Evaluation and Technical Assistance Provider (ETAP)
Health Resources and Services Administration · HRSA-23-127
A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Implementation Sites
Health Resources and Services Administration · HRSA-23-126
CENTERS FOR DISEASE CONTROL CSTLTS · CDC-RFA-TO23-2304
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
National Institutes of Health · PAR-23-155
PS20-2010: Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States (EHE) Component C mpox Supplement
Centers for Disease Control - NCHHSTP · CDC-RFA-PS20-20100101SUPP23
Forest Service · USDA-FS-2023-UCF-IRA-01
Essentials for Childhood (EfC): Preventing Adverse Childhood Experiences through Data to Action
Centers for Disease Control - NCIPC · CDC-RFA-CE-23-0005
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-163
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-119
Development and Validation of Models for Alzheimers Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-154
Health Resources and Services Administration · HRSA-23-081
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans (BESH) Required)
National Institutes of Health · PAR-23-158
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-23-157
Lowlands Health Activity
Ethiopia USAID-Addis Ababa · 72066323RFA00007
Substance Abuse and Mental Health Services Adminis · SM-23-012
Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DE-24-002
Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DE-24-001
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-165